Clinics in Liver Disease

Scope & Guideline

Advancing hepatology through rigorous research.

Introduction

Welcome to the Clinics in Liver Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Clinics in Liver Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1089-3261
PublisherW B SAUNDERS CO-ELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1997 to 2024
AbbreviationCLIN LIVER DIS / Clin. Liver Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899

Aims and Scopes

The journal 'Clinics in Liver Disease' aims to provide comprehensive insights and advances in the field of liver disease management, focusing on a wide range of topics including pathophysiology, diagnosis, treatment, and complications associated with liver disorders. The journal emphasizes evidence-based practices and innovative methodologies to enhance clinical care and research in hepatology.
  1. Portal Hypertension:
    The journal covers extensive research on portal hypertension, including its pathophysiology, complications, management strategies, and surgical interventions.
  2. Hepatic Encephalopathy:
    A significant focus on hepatic encephalopathy is evident, exploring its clinical manifestations, management strategies, and the socio-economic burden it imposes on healthcare systems.
  3. Autoimmune Liver Diseases:
    The journal addresses various autoimmune liver diseases such as autoimmune hepatitis and primary biliary cholangitis, focusing on their pathophysiology, diagnosis, and treatment options.
  4. Chronic Viral Hepatitis:
    Research on chronic viral hepatitis, particularly hepatitis B and C, is a core area, highlighting new therapies, epidemiology, and management challenges.
  5. Nonalcoholic Fatty Liver Disease (NAFLD):
    The journal discusses NAFLD extensively, including its epidemiology, pathogenesis, and the impact of associated conditions such as metabolic syndrome.
  6. Liver Transplantation:
    The scope includes discussions on liver transplantation, donor selection, complications, and post-transplant management, reflecting its critical role in hepatology.
  7. Acute-on-Chronic Liver Failure:
    Research on acute-on-chronic liver failure is prominent, examining its clinical spectrum, management challenges, and therapeutic innovations.
  8. Endoscopic and Interventional Procedures:
    The journal includes studies on endoscopic and interventional radiology techniques for managing liver diseases, emphasizing minimally invasive approaches.
The journal is currently witnessing a trend towards several emerging themes that reflect the evolving landscape of liver disease research and clinical practice. These themes indicate areas of growing interest and significance within the field.
  1. Noninvasive Assessment Techniques:
    There is a growing emphasis on noninvasive assessment methods for liver diseases, particularly in evaluating fibrosis and portal hypertension, as they offer safer alternatives to traditional methods.
  2. Integrated Management of Hepatic Encephalopathy:
    Increased focus on integrated management strategies for hepatic encephalopathy highlights the need for comprehensive care that addresses not only clinical symptoms but also social and economic factors.
  3. Innovative Therapies for Autoimmune Liver Diseases:
    Research into novel therapies for autoimmune liver diseases is on the rise, reflecting advancements in treatment options and a better understanding of disease mechanisms.
  4. Genetic and Metabolic Factors in Liver Disease:
    Emerging research is focusing on the genetic and metabolic underpinnings of liver diseases, particularly in relation to NAFLD and its systemic implications.
  5. Portal Hypertension Complications:
    A significant increase in studies addressing the various complications associated with portal hypertension indicates an expanding understanding and management of this complex condition.

Declining or Waning

While 'Clinics in Liver Disease' maintains a broad focus, certain themes appear to be declining in prominence, reflecting shifts in research priorities and clinical practice. The following areas have seen reduced coverage in recent publications.
  1. Traditional Hepatitis Management:
    There has been a noticeable decline in papers focusing on traditional management strategies for hepatitis, as newer, more effective treatments and approaches are being developed and adopted.
  2. Alcoholic Liver Disease Research:
    Although still relevant, the volume of research specifically addressing alcoholic liver disease has decreased, possibly due to a shift towards more comprehensive metabolic liver disease studies.
  3. Chronic Kidney Disease in Liver Disease:
    Research specifically linking chronic kidney disease with liver disease has waned, likely as more attention is directed toward integrated approaches that encompass broader aspects of liver health.
  4. Liver Biopsy Techniques:
    The frequency of papers discussing liver biopsy techniques has decreased, likely due to the increasing reliance on noninvasive diagnostic methods.
  5. Emerging Biomarkers in Liver Disease:
    Research on emerging biomarkers for liver disease diagnosis and prognosis has seen a decline, possibly overshadowed by advancements in imaging and noninvasive testing.

Similar Journals

Journal of Gastrointestinal and Liver Diseases

Shaping the Future of Gastrointestinal and Liver Research
Publisher: MEDICAL UNIV PRESSISSN: 1841-8724Frequency: 4 issues/year

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.

Gastroenterologia y Hepatologia

Pioneering research for better digestive disease outcomes.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

International Journal of Hepatology

Exploring the frontiers of liver disease management.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Gut and Liver

Transforming patient care through innovative research.
Publisher: EDITORIAL OFFICE GUT & LIVERISSN: 1976-2283Frequency: 6 issues/year

Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.

Annals of Hepatology

Diving deep into the world of hepatology and liver diseases.
Publisher: ELSEVIER ESPANAISSN: 1665-2681Frequency: 6 issues/year

Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.

JGH Open

Connecting Researchers, Transforming Outcomes
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Connecting researchers and clinicians for better outcomes.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

JOURNAL OF HEPATOLOGY

Exploring Breakthroughs in Liver Disease Management
Publisher: ELSEVIERISSN: 0168-8278Frequency: 12 issues/year

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.

Frontline Gastroenterology

Pioneering Research for Liver and Gut Health
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

Saudi Journal of Gastroenterology

Elevating standards in gastrointestinal research and practice.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.